Cellular Origins is an automation manufacturing company that provides cell and gene therapies.
Cellular Origins has raised $40.0M in total funding. The most recent round was Series A. The last funding was announced in December 2025.
Cellular Origins's investors include Highland Europe, Johnson & Johnson Innovation, Innovate UK, NYBC Ventures, BGF Ventures.
Cellular Origins is headquartered in Melbourn, United Kingdom.
Cellular Origins is an automation manufacturing company that provides cell and gene therapies.
Cellular Origins is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Cellular Origins — Funding & Investors." VCBacked, December 9, 2025, https://www.vcbacked.co/company/cellular-origins. Accessed August 14, 2026.
VCBacked. (2025). Cellular Origins — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/cellular-origins
{{cite web |title=Cellular Origins — Funding & Investors |url=https://www.vcbacked.co/company/cellular-origins |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated